Advisor, Baxter
Search every verified Jose Almeida interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a May 2018 interview, Baxter International Chairman and CEO Jose Almeida discussed the company's growth strategy, stating that about two-thirds of projected revenue growth would come from new products and one-third from geographic expansion into markets like Japan and China. Almeida noted that while trade disputes were a concern, he said Baxter would be less affected because 90% of its products in China are made there. He described Baxter as a company focused on basic healthcare products such as injectable saline, glucose, antibiotics, and dialysis, which he said have more stable pricing than some other medical sectors. Almeida identified his biggest internal concern as shifting Baxter's culture to one of "agility, courage, and speed." He said investment decisions hinge on demographics, market size, and the company's ability to grow with the market, and that geopolitical risks are considered but do not deter investment in countries like China due to patient demand. Almeida also stated that Baxter supports broader healthcare coverage and that the volume of patients needing hospital treatment remains stable, which he said supports demand for the company's products.
“Our growth in the top-line is always important because that was we were able to get our margins going up a gross margin going up but we removed this year accumulative of almost 900 million dollars in cost from our our our supply chain.”
“The biggest worry that you have right now as a CEO internally to the company is about our ability to really shift the culture permanently to a culture of agility courage and speed.”
“We are in basic healthcare, injectable saline, glucose, antibiotics, dialysis products so those products usually have more stable pricing. What is the biggest worry that you have right now as a CEO? It hinges upon the demographics, the size of the market in the future and our ability to grow their market or grow with t...”
“If fewer people are covered by insurance, does that mean they're seeking and obtaining less medical services? And does that mean that not as many people are using Baxter products when people get sick? They’ve got to go to the hospital, either through an emergency room access or through a primary care physician.”
“The volume of patients is not changing and we still have people getting sick, getting the flu, going to the hospital, getting treatment. This is when people use Baxter products, our products using ICU for people who are really sick, no matter the mergers in hospitals, we still have beds, people still need to be treated...”
“There's a way of creating synergies on the infrastructure cost, not necessarily removing beds from the system. It's also a way of increasing the pricing power of the hospitals. I mean, there's one thing of how many products are being sold, there is how much you get to charge for. Are you seeing downward pressure becaus...”
“We are not in the pacemaker business, we're in basic healthcare, injectable saline, glucose, antibiotics, dialysis products. Those products usually have more stable pricing. What is the biggest worry that you have right now as a CEO? It hinges upon the demographics, the size of the market in the future and our ability...”
“The ability to really shift the culture permanently to a culture of agility, courage, and speed is our biggest internal challenge. If we can do that, we're going to continue to evolve into a company that is innovative and continues to deliver the bottom line through good growth on the top line.”
“Our investment decision hinges on demographics, the size of the market in the future, and our ability to grow with the market. We look at the market's growth rate and our capacity to expand within it, especially considering geopolitical risks like trade wars or sanctions.”
May.22 -- Baxter International Chairman and Chief Executive Officer Jose Almeida discusses his company's growth forecast and strategy on "Bloomberg Daybreak: Americas." (Video edited to remove incorrect graphic.)
Sign in to search the full transcript archive, filter by topic, and access every quote from Jose Almeida.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →